References
- Posadas SalasMASrinivasTRUpdate on the clinical utility of once-daily tacrolimus in the management of transplantationDrug Des Devel Ther2014811831194
- Garnock-JonesKPTacrolimus prolonged release (Envarsus®): a review of its use in kidney and liver transplant recipientsDrugs201575330932025613762
- BunnapradistSCiechanowskiKWest-ThielkePConversion from twice-daily tacrolimus to once-daily extended release tacrolimus (LCPT): the phase III randomized MELT trialAm J Transplant201313376076923279614
- BuddeKBunnapradistSGrinyoJMNovel once-daily extended-release tacrolimus (LCPT) vs twice-daily tacrolimus in de novo kidney transplants: one-year results of phase III, double-blind, randomized trialAm J Transplant201414122796280625278376
- KrämerBKCharpentierBBäckmanLTacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo transplantation: a randomized phase III studyAm J Transplant201010122632264320840480
- BarracloughKAIsbelNMJohnsonDWCampbellSBStaatzCEOnce-versus twice-daily tacrolimus: are the formulations truly equivalent?Drugs201171121561157721861541
- SilvaHTJrYangHCAbouljoudMOne-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipientsAm J Transplant20077359560817217442
- GrinyoJMPetruzzelliSOnce-daily LCP-Tacro MeltDose tacrolimus for the prophylaxis of organ rejection in kidney and liver transplantationsExpert Rev Clin Immunol201410121567157925407098
- Astagraf XL® (tacrolimus) extended-release capsules [prescribing information]Astellas Pharma US Inc Rev2014
- GaberAOAllowayRRBodziakKKaplanBBunnapradistSConversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipientsTransplantation201396219119723715050
- AllowayRREckhoffDEWashburnWKTepermanLWConversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipientsLiver Transpl201420556457524493215
- FengSChapmanWCDuBayDA phase 2 randomized study of the pharmacokinetics, safety and efficacy of LCP-Tacro tablets once-a-day vs Prograf capsules twice-a-day in de novo liver transplantsPoster presented at: American Transplant Congress 2012June 2–6 2012Boston, MA
- GabardiSNigroVJohnsonMNachtriebRWeinbergJEvaluation of steady-state pharmacokinetic parameters of LCP-Tacro and Advagraf in healthy volunteers using a systems dynamic model [Abstract P330]Transplant International201326Suppl 2185339
Reference
- BuddeKBunnapradistSGrinyoJMNovel once-daily extended-release tacrolimus (LCPT) vs twice-daily tacrolimus in de novo kidney transplants: one-year results of phase III, double-blind, randomized trialAm J Transplant201414122796280625278376